SynAct Pharma AB
STO:SYNACT
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
S
|
SynAct Pharma AB
STO:SYNACT
|
SE |
|
Metro Holdings Ltd
SGX:M01
|
SG |
|
Companhia Energetica do Rio Grande do Norte Cosern
BOVESPA:CSRN3
|
BR |
|
Archer Ltd
OSE:ARCH
|
BM |
|
D
|
Dekuple
XBER:DLU
|
FR |
|
Volt Power Group Ltd
ASX:VPR
|
AU |
|
Gaming and Leisure Properties Inc
NASDAQ:GLPI
|
US |
Wall Street
Price Targets
SYNACT Price Targets Summary
SynAct Pharma AB
According to Wall Street analysts, the average 1-year price target for SYNACT is 30.6 SEK with a low forecast of 30.3 SEK and a high forecast of 31.5 SEK.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is SYNACT's stock price target?
Price Target
30.6
SEK
According to Wall Street analysts, the average 1-year price target for SYNACT is 30.6 SEK with a low forecast of 30.3 SEK and a high forecast of 31.5 SEK.